Quick Facts at a Glance
- Recall Date
- January 29, 2026
- Hazard Level
- HIGH
- Brands
- METOPROLOL SUCCINATE, Actavis Pharma
- Category
- Health & Personal Care
- Sold At
- Multiple Retailers
- Geographic Scope
- 1 states
- At-Risk Groups
- GENERAL, ELDERLY
What to Do Now
Use this page like a recall checklist: verify the product first, then act on the official remedy.
Immediate steps
- 1Stop using the product until you confirm whether it is included in the recall.
- 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
- 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
- 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.
Check these identifiers
- Brand
- METOPROLOL SUCCINATE, Actavis Pharma
- Product type
- Metoprolol Succinate Extended-Release Tablet
- Model numbers
- 0686H251, 0687H251, 10688H251
- UPC codes
- 45963-676, 45963-709, 45963-677, 45963-678, 45963-709-11, 45963-709-96, 45963-676-11, 45963-676-96 +3 more
- Sold at
- Multiple Retailers
- Where affected
- ALL
Recall Timeline
Key dates and source checks for this recall record.
Recall announced
January 29, 2026
Reported by FDA DRUG
March 11, 2026
RecallRadar source check
March 18, 2026
Consumer action
Use the official remedy and keep documentation.
Hazard Information
Failed Dissolution Specifications
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact Teva Pharmaceuticals USA, Inc or your healthcare provider for guidance. Notification method: Letter
About This Product
Metoprolol succinate extended‑release tablets are a prescription medication distributed nationwide by Teva. The 200 mg strength is formulated for chronic conditions requiring beta‑blocker therapy.
Why This Is Dangerous
Dissolution failures can alter how quickly or how much active drug is released, potentially compromising blood pressure control.
Industry Context
This recall is not described as part of a broader industry pattern.
Real-World Impact
Patients with affected bottles may experience reduced drug effectiveness or blood pressure instability. Clinicians should review patients on the affected NDC.
Practical Guidance
How to identify if yours is affected
- Check NDC 45963-678-11 on the bottle label
- Check expiration date: 02/2027
- If any match, stop using immediately
Where to find product info
Recall notice lists NDC, lot numbers, and expiration; contact Teva for guidance.
What timeline to expect
Refunds or replacements follow Teva's process; typically 4-8 weeks after eligibility is confirmed.
If the manufacturer is unresponsive
- Document all communications
- Consult your healthcare provider for interim guidance
- File a report with FDA MedWatch if needed
How to prevent similar issues
- Verify NDC and lot numbers upon receipt of prescriptions
- Keep medications in original packaging with label intact
- Watch for recall notices from FDA and manufacturers
Documentation advice
Save recall notices, bottle labels, lot numbers, and all correspondence; photograph bottles and labels for records.
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Product Details
- NDC: 45963-678-11\n- Product: Metoprolol Succinate Extended-Release Tablets, 200 mg\n- Bottles per package: 100 tablets\n- Quantity recalled: 19,056 bottles\n- Lot numbers: 0686H251, 0687H251, 10688H251\n- Expiration: 02/2027\n- Brand: METOPROLOL SUCCINATE\n- Manufacturer: Teva Pharmaceuticals USA, Parsippany, NJ\n- Sold nationwide\n- Recall date: 2026-01-29
Key Facts
- Lot numbers 0686H251, 0687H251, 10688H251
Browse More Recalls
Safety Guide
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet Alerts for Health & Personal Care Recalls
Get instant alerts for recalls that affect you. Free forever.